Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 22

Results For "RSE"

1712 News Found

in-cosmetics Asia 2025 smashes records, draws global beauty elite
News | November 21, 2025

in-cosmetics Asia 2025 smashes records, draws global beauty elite

Over 700 exhibitors from APAC, Europe, the US, and beyond showcased the latest in personal care innovation


Meduloc wins FDA green light for new class of bone-fracture fixation system
Medical Device | November 19, 2025

Meduloc wins FDA green light for new class of bone-fracture fixation system

The cleared system pairs a flexible nitinol implant with a deployable prong-locking mechanism, delivering rotational and length stability


Roche’s Giredestrant sets new benchmark in early breast cancer treatment
Clinical Trials | November 19, 2025

Roche’s Giredestrant sets new benchmark in early breast cancer treatment

The study met its primary endpoint, demonstrating a statistically significant and clinically meaningful improvement in invasive disease-free survival


WHO issues first global guidelines for managing diabetes in pregnancy
Healthcare | November 17, 2025

WHO issues first global guidelines for managing diabetes in pregnancy

Uncontrolled diabetes in pregnancy dramatically increases the risk of pre-eclampsia, stillbirth, birth injuries, and long-term cardiometabolic diseases


Amcor launches ultra-light Shadow roll-on for next-gen beauty branding
Packaging | November 16, 2025

Amcor launches ultra-light Shadow roll-on for next-gen beauty branding

The new shadow roll-on delivers strong on-shelf presence with its modern rounded-base design


Daiichi Sankyo launches first-in-human trial of innovative cancer therapy
Clinical Trials | November 14, 2025

Daiichi Sankyo launches first-in-human trial of innovative cancer therapy

The trial will evaluate safety endpoints including dose-limiting toxicities and adverse events


Pfizer completes up to $10 billion acquisition of Metsera
News | November 14, 2025

Pfizer completes up to $10 billion acquisition of Metsera

Acquisition brings highly differentiated clinical-stage obesity candidates with potential to reshape the treatment landscape